1. Home
  2. ACCD vs CGEM Comparison

ACCD vs CGEM Comparison

Compare ACCD & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACCD
  • CGEM
  • Stock Information
  • Founded
  • ACCD 2007
  • CGEM 2016
  • Country
  • ACCD United States
  • CGEM United States
  • Employees
  • ACCD N/A
  • CGEM N/A
  • Industry
  • ACCD Business Services
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACCD Consumer Discretionary
  • CGEM Health Care
  • Exchange
  • ACCD Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • ACCD 569.3M
  • CGEM 506.1M
  • IPO Year
  • ACCD 2020
  • CGEM 2021
  • Fundamental
  • Price
  • ACCD $6.99
  • CGEM $8.24
  • Analyst Decision
  • ACCD Hold
  • CGEM Strong Buy
  • Analyst Count
  • ACCD 11
  • CGEM 8
  • Target Price
  • ACCD $6.22
  • CGEM $32.86
  • AVG Volume (30 Days)
  • ACCD 997.3K
  • CGEM 431.7K
  • Earning Date
  • ACCD 04-24-2025
  • CGEM 05-14-2025
  • Dividend Yield
  • ACCD N/A
  • CGEM N/A
  • EPS Growth
  • ACCD N/A
  • CGEM N/A
  • EPS
  • ACCD N/A
  • CGEM N/A
  • Revenue
  • ACCD $446,718,000.00
  • CGEM N/A
  • Revenue This Year
  • ACCD $14.47
  • CGEM N/A
  • Revenue Next Year
  • ACCD $12.51
  • CGEM $278.37
  • P/E Ratio
  • ACCD N/A
  • CGEM N/A
  • Revenue Growth
  • ACCD 14.99
  • CGEM N/A
  • 52 Week Low
  • ACCD $3.08
  • CGEM $7.90
  • 52 Week High
  • ACCD $10.68
  • CGEM $30.19
  • Technical
  • Relative Strength Index (RSI)
  • ACCD 76.18
  • CGEM 42.29
  • Support Level
  • ACCD $6.95
  • CGEM $8.37
  • Resistance Level
  • ACCD $6.99
  • CGEM $9.16
  • Average True Range (ATR)
  • ACCD 0.02
  • CGEM 0.52
  • MACD
  • ACCD -0.03
  • CGEM 0.07
  • Stochastic Oscillator
  • ACCD 90.00
  • CGEM 41.26

About ACCD Accolade Inc.

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: